The federal committee responsible for advising scientists, health agencies, and Congress on autism research has canceled its first scheduled public meeting since undergoing a significant membership overhaul earlier this year, according to federal health officials.

The Interagency Autism Coordinating Committee was set to convene on March 19 for the first time in more than a year, but Department of Health and Human Services spokesperson Andrew Nixon confirmed the cancellation without providing an explanation.

“The IACC will not meet later this month. Further information will be shared as available,” Nixon said in a statement.

The cancellation follows controversy surrounding Health Secretary Robert F. Kennedy Jr.’s recent appointments to the committee, which scientists say departed from the panel’s traditional composition. According to reports, Kennedy stacked the body with members who support his views linking autism and vaccines, a connection that has been thoroughly debunked by scientific research. As documented in recent reporting on clinical practice changes, the administration’s messaging on this topic has already begun influencing medical decision-making across healthcare settings.

Historically, the committee included researchers with mainstream scientific perspectives and autistic self-advocates who provided input on federal autism research priorities and policy recommendations.

The timing of the cancellation has drawn additional attention as it comes just days after scientists established an independent alternative to the federal panel. This new group formed in direct response to the changes in the official committee’s membership composition.

Helen Tager-Flusberg, director of the Center for Autism Research Excellence at Boston University and a member of the newly formed independent group, confirmed that their organization will proceed with its planned March 19 meeting despite the federal committee’s cancellation.

“The independent group, which had planned to meet on the same day, will still gather on March 19,” Tager-Flusberg said.

The federal committee’s future meeting schedule remains uncertain, though one committee member indicated on social media that the group might reconvene in April, according to reports.

The Interagency Autism Coordinating Committee plays a crucial role in coordinating autism research efforts across multiple federal agencies and provides recommendations for research priorities and funding allocation. The committee’s work influences how federal resources are directed toward autism research, services, and support programs.

The controversy surrounding the committee’s restructuring reflects broader tensions within the autism research community about research priorities and the direction of federal policy. Traditional autism research has focused on understanding the neurological and genetic factors contributing to autism spectrum disorders, while also working to improve services and support for autistic individuals and their families.

The formation of the independent committee represents an attempt by mainstream researchers to maintain continuity in evidence-based autism research and advocacy. This parallel organization aims to provide scientific guidance that aligns with established research methodologies and peer-reviewed findings.

For Hawaii’s medical and research communities, the federal committee’s work has implications for local autism research funding and service development. The state’s medical institutions and healthcare providers often rely on federal guidelines and research priorities when developing autism-related programs and services.

The cancellation leaves questions about when federal autism research coordination will resume and how the changes in committee composition might affect future research directions and funding decisions. Healthcare professionals and researchers in Hawaii and other states await clarity on the committee’s next steps and the potential impact on autism research and services nationwide.

The situation continues to develop as both the restructured federal committee and the newly formed independent group work to establish their respective roles in guiding autism research and policy.